Indian version of Iressa Iressa GEFTINAT and the difference between UK
&quot;Costly treatment of a grant exclusive rights to prohibit the use of another
utility is the same one-fifth of the cost of drugs is a violation of humanitarian
principles. In fact, the implementation of the exclusive rights to make Tens of
thousands of patients are taking GEFTINAT not have access to this drug, the result
means to deal with patients who can not afford expensive drugs sentenced to death.
&quot;Policy should be repeated at least consider the non-economic relations,
medicine, critical and life-saving medicine.&quot;
----- Natco Pharma, vice president of business development, Rajeev Nannapaneni
Article on the Indian pharmaceutical company NATCO GEFTINAT (gefitinib tablets)
and AstraZeneca Iressa make the difference between a simple explanation:
Q: What is GEFTINAT
A: GEFTINAT is produced by the Indian NATCO treatment of advanced non-small
cell lung cancer rake to the anti-tumor drugs, red brown to 500mg tablets, each tablet
containing gefitinib 250mg. Natco Pharma Ltd (NPL), is located in Fort Hydra, assets
of 900 million five thousand rupees, a pharmaceutical company, for its research
strength and is known for timely release of technical information.
Q: India Iressa GEFTINAT (gefitinib tablets) and AstraZeneca Iressa, where the
A: As we all know, Iressa AstraZeneca launched the British treatment of advanced
non-small cell lung cancer rake to the anti-tumor drugs, the active ingredient is
Gefitinib (Gefitinib), as a molecular target drugs, the current leading status, the
treatment of advanced non-small cell lung cancer, after failure of chemotherapy in
particular, non-small cell lung cancer the best treatment. India Iressa GEFTINAT
(gefitinib tablets) produced by Natco in India, is AstraZeneca&#39;s Iressa
generic. Iressa and GEFTINAT are registered trademarks of their respective
companies. It is noteworthy that AstraZeneca Iressa is the world&#39;s patent
applications are in the world of intellectual property protection of drugs, so most of
the countries to reach WTO agreement can not be generic in their protection during
the drug. Iressa India is GEFTINAT is Indian brand to be registered, and does not get
registered in other countries, including China market. and because AstraZeneca Iressa
patent exists to NATCO&#39;s Iressa patent period will not get in countries
outside India trademark registration.
India and the UK version of Iressa Iressa main difference lies here.
Q: India Iressa GEFTINAT (gefitinib tablets) and AstraZeneca&#39;s Iressa,
where common ground
A: Both the active ingredients are Gefitinib (Gefitinib). Natco Iressa GEFTINAT
company said its the best Indian pharmaceutical and chemical engineers develop the
process technology. India and the UK version of Iressa Iressa major difference in who
is doing, do people have in different patents. Difference is not in active ingredients.
Q: Why is the market can only see AstraZeneca Iressa, but do not see India Iressa
GEFTINAT (gefitinib tablets)
A: AstraZeneca Iressa products for various countries and regions around the world
applied for a patent exclusive. That is, the protection period, a country region, only
AstraZeneca Iressa can contain active ingredients sales Gefitinib (Gefitinib). The legal
drugs. India Iressa GEFTINAT (gefitinib tablets) is currently only recognized by the
Government of India and can be legally produced. India Iressa GEFTINAT (gefitinib
tablets) in any distribution in China act constitutes a breach of Chinese Medicine Act,
AstraZeneca will retain their legal rights.
Q: How to Buy India Iressa GEFTINAT (gefitinib tablets)
A: India Iressa GEFTINAT (gefitinib tablets) can be purchased in India, or through
mail order sources. For overseas markets, currently overseas, Natco does not direct
sales (including mail order), can only be achieved through a third party.
You can see from here, India and the UK version of Iressa Iressa difference is that, in
the country, selling the UK version of the Iressa is protected by law, but the
commercial use of Iressa sales in India&#39;s illegal, This is the so-called no
country Yaozhun Zi, the so-called &quot;fake.&quot;
Q: Personal Mail Order India Iressa GEFTINAT (gefitinib tablets) is valid
A: Although not allowed to import patented drugs after the expiry date of such Veenat
for commercial purposes, but imported for personal use is legal.
Q: Does a reliable third-party Shopping Service
A: In the absence of better ways and methods of payment before buying, to find a
reliable third-party Shopping Service is a successful purchase and a good way to
achieve a certain amount, but it is highly recommended to buy a single number no
more than 2-3 bottles.
Q: India Iressa GEFTINAT (gefitinib tablets) and AstraZeneca Iressa is as effective as
A: There are currently no medical evidence to prove India Iressa GEFTINAT
(gefitinib tablets) and AstraZeneca Iressa is in effect, What&#39;s the difference,
but it has a lot of advanced non-small cell lung cancer patients is easy to Switzerland
in India Sand GEFTINAT (gefitinib tablets) and tumor volume in the hematology and
gain some relief, objective response in 30% and 50% -60% of patients have access to
physical relief, such as pain relief, cough, hemoptysis, etc. There seemed to be less
efficient and Iressa, AstraZeneca reported similar efficiency. Similarly, AstraZeneca
Iressa for only a certain proportion of cancer patients can get relief opportunities.
Domestic hospitals and no clinical use of IRESSA for the Indian record, but for some
doctors to India with the active ingredient Iressa Gefitinib (Gefitinib). That
Q: How taking Iressa
A: From the current situation of drug taking groups of view, please communicate with
your physician to determine that advanced non-small cell carcinoma (adenosquamous
carcinoma), and chemotherapy failed, or not prepared to take the case of
chemotherapy take one of the best treatment. daily dose of 250mg no day is the day
one, sooner or later can take.; theoretically provide a more intuitive doctor
recommendations. Iressa may also refer to the instructions in Chinese.